You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkin Disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thereapeutic Recommendantion for a Hodgkin Lymphoma

Not yet recruiting
  • Staging
  • Therapeutic Recommendations
  • Observational
  • Paris, France
    Brenda Mallon
Sep 20, 2022

Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
Aug 5, 2022

Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 18, 2022

Hodgkin Lymphoma, Adult, Hodgkin Disease Recurrent, Hodgkin Disease Refractory Trial in United States (CD30.CAR-T, Fludarabine,

Active, not recruiting
  • Hodgkin Lymphoma, Adult
  • +3 more
  • Duarte, California
  • +4 more
Apr 3, 2022

Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

Withdrawn
  • Hodgkin Lymphoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 28, 2022

Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • (no location specified)
Jul 28, 2022

Hodgkin's Disease Trial in Boston (Echo/Stress Echo)

Active, not recruiting
  • Hodgkin's Disease
  • Echo/Stress Echo
  • Boston, Massachusetts
  • +1 more
Mar 28, 2022

Hodgkin Lymphoma Trial (pembrolizumab, brentuximab vedotin)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • brentuximab vedotin
  • (no location specified)
Aug 18, 2022

Lung Cancer, Esophageal Cancer, Thoracic Cancer Trial in Saint Louis (Home-based cardiac rehabilitation)

Recruiting
  • Lung Cancer
  • +8 more
  • Home-based cardiac rehabilitation
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 9, 2022

Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Aug 5, 2022

Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal

Recruiting
  • Young Adults
  • +2 more
  • Indirect calorimetric test during submaximal exercise
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
May 3, 2022

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Duarte, California
  • +4 more
Jun 27, 2022

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

Active, not recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Classical Hodgkin Lymphoma Trial in Cologne (Pembrolizumab plus Chemotherapy (ICE or DHAP))

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Pembrolizumab plus Chemotherapy (ICE or DHAP)
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Aug 5, 2022

Biospecimen Procurement for Center for Immuno-Oncology

Recruiting
  • Multiple Myeloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 13, 2022

    Hodgkin Lymphoma Trial in Australia, New Zealand (pembrolizumab)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Concord, New South Wales, Australia
    • +5 more
    Nov 3, 2022

    Hodgkin Lymphoma Trial in Moscow (Nivolumab)

    Recruiting
    • Hodgkin Lymphoma
    • Moscow, Russian Federation
      The Federal Budget-Funded Institution National Medical Surgical
    Oct 31, 2022

    Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin

    Recruiting
    • Hodgkin Lymphoma
      • Naples, Italy
        Federico II University
      Feb 15, 2022

      Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

      Active, not recruiting
      • Peripheral T Cell Lymphoma
      • Pediatric Hodgkin Lymphoma
      • Brentuximab Vedotin (Genetical Recombination)
      • Tokyo, Japan
        Takeda Selected Site
      Oct 11, 2022

      Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)

      Recruiting
      • Safety Issues
      • Efficacy, Self
      • low dose nivolumab in combination with AVD
      • Monterrey, Nuevo Leon, Mexico
        Hospital Universitario Dr Jose Eleuterio Gonzalez
      Mar 6, 2023

      Hodgkin's Lymphoma Trial in Seattle (Pembrolizumab, Umbralisib)

      Terminated
      • Hodgkin's Lymphoma
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 22, 2022

      Recurrent/Refractory Classical Hodgkin's Lymphoma Trial in Tianjin (AK105,Anrotinib HCl)

      Enrolling by invitation
      • Recurrent/Refractory Classical Hodgkin's Lymphoma
      • AK105，Anrotinib hydrochloride
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Insititute & Hospital
      Jan 12, 2023